Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.
Yi-Chun HuaDe-Zhi GaoKuan-Yu WangXiao-Sheng DingWei-Ran XuYu-Bin LiWei-Wei ShiShi-Bin SunXiao-Yan LiPublished in: Thoracic cancer (2023)
Bevacizumab significantly reduces the severity of PTBE after radiotherapy for lung cancer. However, its impact on tumor volume reduction and intracranial PFS does not reach statistical significance.